Coronavirus-disease-19 (COVID-19) continues to affect millions of individuals worldwide. Antiviral activity of mouthrinses remains an important research area as the oral cavity is a site of SARS-CoV-2 initial replication. The aim of this study was to assess the effectiveness of three different mouthrinses in reducing the oral/oropharyngeal SARS-CoV-2 viral load.
Efficacy of antiseptic mouthrinses against SARS-CoV-2: A prospective randomized placebo-controlled pilot study / Fantozzi, Paolo Junior; Pampena, Emanuele; Pierangeli, Alessandra; Oliveto, Giuseppe; Sorrentino, Leonardo; Di Vanna, Domenico; Pampena, Riccardo; Lazzaro, Alessandro; Gentilini, Elio; Mastroianni, Claudio Maria; D'Ettorre, Gabriella; Polimeni, Antonella; Romeo, Umberto; Villa, Alessandro. - In: AMERICAN JOURNAL OF OTOLARYNGOLOGY. - ISSN 0196-0709. - 43:6(2022). [10.1016/j.amjoto.2022.103549]
Efficacy of antiseptic mouthrinses against SARS-CoV-2: A prospective randomized placebo-controlled pilot study
Fantozzi, Paolo Junior;Pierangeli, Alessandra;Sorrentino, Leonardo;Lazzaro, Alessandro;Gentilini, Elio;Mastroianni, Claudio Maria;D'Ettorre, Gabriella;Polimeni, Antonella;Romeo, Umberto
;
2022
Abstract
Coronavirus-disease-19 (COVID-19) continues to affect millions of individuals worldwide. Antiviral activity of mouthrinses remains an important research area as the oral cavity is a site of SARS-CoV-2 initial replication. The aim of this study was to assess the effectiveness of three different mouthrinses in reducing the oral/oropharyngeal SARS-CoV-2 viral load.| File | Dimensione | Formato | |
|---|---|---|---|
|
Fantozzi_Efficacy-of-antiseptic_2022.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
395.73 kB
Formato
Adobe PDF
|
395.73 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
